Adempas

Indicated For

Pulmonary Arterial Hypertension (PAH), Chronic Thromboembolic Pulmonary Hypertension (CTEPH)

About This Medication

# Aim Patient Support Program Guide: How to Get Adempas at Low or No Cost ## About This Program The **Aim Patient Support Program** is Bayer's patient assistance program designed to help eligible patients access Adempas (riociguat) at reduced or no cost. Adempas is a prescription medication used to treat two serious lung conditions: chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension (PAH). If you've been prescribed Adempas but are concerned about the cost, this program may be able to help. ## What Is Adempas? Adempas is a soluble guanylate cyclase stimulator—a type of medication that works by relaxing blood vessels in the lungs and improving blood flow. It's prescribed to help patients with CTEPH or PAH breathe easier and reduce symptoms like shortness of breath and fatigue. Because this is a specialized medication for rare conditions, it can be expensive. The Aim Patient Support Program exists to ensure cost doesn't prevent you from getting the treatment you need. ## Who Can Apply? You may be eligible for the Aim Patient Support Program if you meet these criteria: - **You have a valid prescription** for Adempas from your doctor - **You have private commercial insurance** with a co-pay or coinsurance obligation - **You are NOT enrolled in Medicare or Medicaid** (these patients should explore other resources) - **You are a U.S. resident** - **You meet income requirements** (see income table below) - **You are enrolled in the Adempas REMS program** (a required safety monitoring program) ## Income Eligibility Income limits vary based on your household size. Contact the program directly at **(855) 423-3672** for specific income thresholds, as they may be adjusted periodically. Generally, the program is designed to help patients with limited financial resources, but exact limits depend on your family size and circumstances. **Note:** If your income exceeds the threshold, you may still qualify for the Adempas Savings Card, which can reduce your out-of-pocket costs. ## Insurance Requirements This program is specifically designed for patients with: - **Private commercial health insurance** (not Medicare or Medicaid) - **Active co-pays or coinsurance** obligations for Adempas If you have Medicare or Medicaid, you are not eligible for this program. However, you may benefit from: - State pharmaceutical assistance programs - Medicare Extra Help programs - Your state's Medicaid programs - The Adempas Savings Card (in some cases) Contact the program at **(855) 423-3672** for alternative resources if you have government insurance. ## Documents You'll Need Before you apply, gather these required documents: 1. **A valid prescription for Adempas** from your doctor 2. **Proof of current insurance** (insurance card or benefits statement) 3. **Proof of Adempas REMS enrollment** (your doctor should provide this) 4. **Income documentation** (if requested) — such as recent pay stubs, tax returns, or proof of benefits 5. **Identification** — a government-issued ID ## How to Apply: Step-by-Step **Step 1: Enroll in the Adempas REMS Program** Before applying for patient assistance, you must be enrolled in the Adempas REMS (Risk Evaluation and Mitigation Strategy) program. This is a safety requirement for all Adempas patients. Your doctor will help you enroll or confirm you're already registered. **Step 2: Contact the Aim Patient Support Program** Call **(855) 423-3672** to request an application or apply online at **https://www.adempas-us.com/aim-access-and-financial-support**. A program representative can answer questions about eligibility, income requirements, and the application process. They can also help you apply over the phone if that's easier for you. **Step 3: Complete Your Application** You can apply through multiple methods: - **Online** via the program website - **Phone** by calling the number above - **Mail** if you prefer paper forms The application asks for basic information about: - Your household income - Current insurance coverage - Your prescription and medical condition - Employment status - Family size and composition **Step 4: Submit Required Documents** Include copies of: - Your insurance card - Proof of income (if required) - Your prescription - REMS enrollment confirmation **Step 5: Wait for Approval** The program typically processes applications within **2-4 weeks**. A program representative will contact you with a decision. **Step 6: Receive Your Medication** If approved, Adempas will be shipped directly to you or to your physician's office through a specialty pharmacy. The specialty pharmacy will coordinate delivery and handle any insurance questions. ## Timeline and What to Expect - **Application processing:** 2-4 weeks - **Delivery:** Your medication ships via specialty pharmacy after approval - **Ongoing support:** A case manager may contact you to answer questions - **Reauthorization:** You must reapply **annually** to continue receiving assistance ## Using a Savings Card If you don't qualify for the full patient assistance program, or if you want additional savings, the **Adempas Savings Card** may help reduce your co-pays. Details and eligibility information are available at **https://www.adempas-us.com/aim-access-and-financial-support**. ## What If You're Denied? If your application is denied, you have several options: 1. **Ask why** — Request detailed feedback about what didn't qualify 2. **Appeal** — Some denials can be appealed; ask about the process 3. **Explore alternatives:** - State pharmaceutical assistance programs - Patient advocacy organizations for lung disease - Clinical trials (ask your doctor) - Reduced-cost care programs at local hospitals or clinics - NeedyMeds.org for additional resources 4. **Contact your doctor** — Your physician may have additional resources or samples available ## Annual Reauthorization Your assistance doesn't last forever. You must **reapply every year** to continue receiving help through the Aim Patient Support Program. The program will contact you before your assistance expires to remind you to reapply. Don't miss this deadline, or you may face a gap in coverage. ## Frequently Asked Questions **Q: I have Medicare. Can I use this program?** A: No. This program is only for patients with private commercial insurance. Contact **(855) 423-3672** for Medicare alternatives. **Q: How much will my medication cost?** A: Costs vary based on your income and insurance. Some patients pay nothing; others pay a reduced co-pay. The program will tell you the exact cost during approval. **Q: Can my doctor apply on my behalf?** A: Yes. Your doctor's office can help with the application. Call the program to ask about physician-assisted applications. **Q: What if my income changes?** A: Report income changes when they occur. Your eligibility may change, but the program wants to work with you. **Q: How long will I need Adempas?** A: That depends on your condition and your doctor's recommendations. Many patients use it long-term, which is why annual reauthorization is required. ## Important Reminders - **Keep your REMS enrollment current** — This is required to receive Adempas - **Don't miss reauthorization deadlines** — Reapply before your assistance expires - **Report life changes** — New income, insurance, or address changes should be reported to the program - **Ask questions** — The program team is available to help. Call **(855) 423-3672** anytime ## Contact Information **Aim Patient Support Program** - **Phone:** (855) 423-3672 - **Website:** https://www.adempas-us.com/aim-access-and-financial-support - **Hours:** Typically Monday-Friday, 8 AM - 8 PM ET ## Legal Disclaimer This guide provides general information about the Aim Patient Support Program and is not a guarantee of enrollment or benefits. Program eligibility, requirements, and benefits may change. Always verify current information with the program directly by calling **(855) 423-3672** or visiting the official website. This guide is not medical advice; consult your doctor about your Adempas prescription and treatment plan. Bayer reserves the right to modify or discontinue this program at any time.

Program information last verified: March 25, 2026